BiEst is short for “biestrogen,” a compounded hormone preparation that combines two types of estrogen: estriol and estradiol. These are bioidentical hormones, meaning they’re chemically identical to the estrogen your body naturally produces. BiEst is most commonly prescribed to relieve menopause symptoms like hot flashes, night sweats, and vaginal dryness.
What BiEst Contains
The standard BiEst formula uses an 80:20 ratio of estriol to estradiol. In a typical cream, that translates to 0.4% estriol and 0.1% estradiol per dose. Both hormones are derived from plant sources, usually wild yam, and then processed in a lab to match the molecular structure of the estrogens your ovaries produce.
Estriol is the weaker of the two estrogens. It binds to estrogen receptors in your body but lets go more quickly and with less intensity than estradiol. Estradiol is the more potent form, binding tightly to receptors and producing stronger effects. The idea behind the 80:20 ratio is to deliver a gentler overall estrogenic effect by relying mostly on the milder hormone while still including a small amount of the stronger one.
There’s also a related formula called TriEst, which adds a third estrogen (estrone) to the mix. BiEst is the more commonly prescribed of the two.
How BiEst Differs From Standard HRT
Conventional hormone replacement therapy typically uses either synthetic estrogens or conjugated equine estrogens (derived from horse urine, sold under brand names like Premarin). BiEst uses hormones that are structurally identical to human estrogen rather than chemically modified versions of it. This structural difference matters because bioidentical hormones and synthetic hormones can produce distinctly different physiological effects in the body, sometimes even opposite ones.
Some clinical data suggests bioidentical hormones carry lower risks of breast cancer and cardiovascular disease compared to synthetic and animal-derived alternatives. However, the comparison is complicated by the fact that most BiEst is compounded (mixed by specialty pharmacies for individual patients) rather than mass-manufactured, which creates its own set of concerns around quality and consistency.
How It’s Prescribed and Used
BiEst comes in several forms: transdermal creams, gels, capsules, and troches (small lozenges that dissolve under the tongue). Creams applied to the skin are the most common delivery method. A typical starting dose is half a gram of cream applied twice daily, with the dose adjusted up or down based on how you respond. If hot flashes persist, the dose goes up; if breast tenderness develops, it comes down.
Some people who don’t respond well to the cream are switched to a sublingual form, which absorbs through the tissue under the tongue and enters the bloodstream more directly. Dosing is individualized, often guided by symptom tracking and sometimes by saliva or blood hormone level testing.
What BiEst Is Used For
BiEst is primarily prescribed for people going through perimenopause or menopause whose dropping estrogen levels cause disruptive symptoms. The most common reasons people seek it out include hot flashes, night sweats, vaginal dryness, painful intercourse, sleep problems, fatigue, weight changes, mood swings, and memory difficulties. These all stem from the same underlying hormonal shift, and replacing some of that lost estrogen can ease or resolve many of them.
FDA Status and Regulation
This is where BiEst gets controversial. Most BiEst preparations are compounded, meaning they’re mixed by specialty pharmacies based on an individual prescription rather than manufactured by a pharmaceutical company. Compounded drugs are exempt from FDA approval requirements, good manufacturing practice standards, and the labeling rules that apply to commercial medications. The FDA does not review them for safety, effectiveness, or quality before they reach patients.
It’s worth noting that bioidentical estradiol itself is available in FDA-approved commercial products (patches, pills, gels). What makes BiEst different is the addition of estriol in a custom ratio and the compounding process. The American College of Obstetricians and Gynecologists recommends that FDA-approved hormone therapies be used over compounded bioidentical preparations when an approved option exists, largely because of the quality control and safety testing gap.
Risks and Side Effects
Because BiEst contains estrogen, it carries the same fundamental risks as any estrogen therapy. The FDA’s strongest warnings on estrogen products flag increased risks of breast cancer (especially when combined with a progestogen), endometrial cancer, stroke, coronary artery disease, blood clots, and possibly ovarian cancer. One large study also found a higher risk of dementia in postmenopausal women over 65 taking oral estrogen with a progestogen.
More common, less serious side effects include headaches, bloating, nausea, breast tenderness, mood changes, weight fluctuation, and skin reactions at the application site for creams. Some people experience fluid retention, changes in sex drive, or joint pain.
BiEst is not appropriate for people with a history of breast or endometrial cancer, blood clotting disorders, stroke, heart attack, abnormal genital bleeding, or known allergic reactions to estrogen products. People with clotting-related conditions like deep vein thrombosis or pulmonary embolism, or inherited clotting disorders, should also avoid it.
Proponents of BiEst argue that the heavy estriol component makes it safer than estradiol-only therapies because estriol is a weaker estrogen. There is some physiological basis for this: estriol disconnects from estrogen receptors roughly six times faster than estradiol does, which limits how long it stimulates cells. But “weaker” does not mean risk-free, and the long-term safety of BiEst specifically has not been studied in the kind of large, controlled trials that FDA-approved hormones undergo.